Advertisement

Mersana Therapeutics Inc has raised $6 million of a planned $10 million debt round with private investors, the company reported in a regulatory filing on Thursday. 

The Cambridge company develops medicines using a proprietary, biodegradable polymer it calls Fleximer.

SOURCE

Advertisement
Advertisement